Michael Scolaro

Michael Scolaro

Aug 28, 2017

Group 6 Copy 195
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Synthesis of a Kidney Cancer Drug

    We need to prepare a 75 mg sample of our anti-kidney cancer drug for testing. The sample was requested by...

    Activating brown fat to improve diabetes and obesity

    Diabetes in childhood is life changing, needing daily insulin injections to get strict blood sugar control...

    Improving Collaborations for Neglected Tropical Diseases

    Neglected tropical diseases (NTDs) infect over a billion of the poorest people in the world, yet only a...

    Backer Badge Funded